VAS
BSX icon

Vestmark Advisory Solutions’s Boston Scientific BSX Stock Holding History

Vestmark Advisory Solutions’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Sell
71,743
-74,850
-51% -$4.06M 0.03% 543
2026
Q1 		$9.2M Buy
146,593
+84,748
+137% +$6.78M 0.1% 206
2025
Q4 		$5.9M Buy
61,845
+6,558
+12% +$643K 0.08% 259
2025
Q3 		$5.4M Buy
55,287
+9,761
+21% +$1.01M 0.1% 196
2025
Q2 		$4.89M Sell
45,526
-33,131
-42% -$3.35M 0.07% 205
2025
Q1 		$7.93M Buy
78,657
+35,721
+83% +$3.6M 0.2% 131
2024
Q4 		$3.84M Sell
42,936
-894
-2% -$78.7K 0.13% 162
2024
Q3 		$3.67M Buy
43,830
+6,066
+16% +$478K 0.14% 153
2024
Q2 		$2.91M Buy
37,764
+288
+0.8% +$21.1K 0.12% 186
2024
Q1 		$2.57M Sell
37,476
-1,501
-4% -$96.5K 0.11% 212
2023
Q4 		$2.25M Sell
38,977
-339
-0.9% -$18.1K 0.11% 210
2023
Q3 		$2.08M Buy
39,316
+22,900
+139% +$1.2M 0.15% 168
2023
Q2 		$888K Sell
16,416
-976
-6% -$51K 0.03% 480
2023
Q1 		$870K Buy
17,392
+336
+2% +$15.8K 0.04% 469
2022
Q4 		$789K Buy
17,056
+5,135
+43% +$222K 0.04% 476
2022
Q3 		$462K Sell
11,921
-183
-2% -$7.34K 0.03% 552
2022
Q2 		$451K Sell
12,104
-370
-3% -$15.1K 0.03% 564
2022
Q1 		$552K Buy
12,474
+395
+3% +$17.1K 0.03% 506
2021
Q4 		$513K Sell
12,079
-2,871
-19% -$121K 0.03% 538
2021
Q3 		$649K Buy
14,950
+279
+2% +$12.3K 0.04% 425
2021
Q2 		$627K Sell
14,671
-7,468
-34% -$314K 0.04% 415
2021
Q1 		$856K Buy
22,139
+2,685
+14% +$102K 0.08% 328
2020
Q4 		$699K Buy
19,454
+1,946
+11% +$70.1K 0.08% 295
2020
Q3 		$669K Buy
17,508
+2,154
+14% +$83K 0.09% 274
2020
Q2 		$539K Buy
15,354
+1,664
+12% +$59.9K 0.08% 286
2020
Q1 		$447K Buy
13,690
+203
+2% +$7.93K 0.09% 286
2019
Q4 		$610K Sell
13,487
-1,423
-10% -$59.5K 0.13% 192
2019
Q3 		$607K Buy
14,910
+47
+0.3% +$1.99K 0.1% 259
2019
Q2 		$639K Sell
14,863
-905
-6% -$34.8K 0.11% 242
2019
Q1 		$605K Buy
+15,768
New +$602K 0.11% 247

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vestmark Advisory Solutions's BSX Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Boston Scientific (BSX) stake by 51% in Q2 2026, selling an estimated $4.06M and leaving 71,743 shares worth $3.06M. The position accounts for 0.03% of the portfolio, ranked #543.

Vestmark Advisory Solutions first reported a position in BSX in Q1 2019 and has held it in 30 quarters since. The position peaked at $9.2M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vestmark Advisory Solutions held 71,743 shares of Boston Scientific worth $3.06M as of Q2 2026.
  • Vestmark Advisory Solutions sold 74,850 Boston Scientific shares in Q2 2026, an estimated $4.06M.
  • Boston Scientific made up 0.03% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #543 holding.
  • Vestmark Advisory Solutions first reported a position in Boston Scientific in Q1 2019 and has held it in 30 quarters since.
  • Vestmark Advisory Solutions's Boston Scientific position peaked at $9.2M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.